-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
PMV Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2024.
- PMV Pharmaceuticals, Inc. Depreciation for the quarter ending June 30, 2024 was $372K, a 0.81% increase year-over-year.
- PMV Pharmaceuticals, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.45M, a 111% increase year-over-year.
- PMV Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.26M, a 299% increase from 2022.
- PMV Pharmaceuticals, Inc. annual Depreciation for 2022 was $315K, a 2.61% increase from 2021.
- PMV Pharmaceuticals, Inc. annual Depreciation for 2021 was $307K, a 3.46% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)